I think that’s right Micko. I also seemed to recall some mention of a revised TGA (Aus) regulatory application based on the new EU certification process. I also think there was mention of the FDA submission for bile duct. All of this of course never seems to end. As we have not seen any other than the CE Mark.
Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-8
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.66M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $4.47K | 886.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6296690 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 22890532 | 25 |
View Market Depth
| Last trade - 14.42pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 2050000 | ||
| Last updated 14.42pm 14/06/2024 ? | |||||
| OSL (ASX) Chart |